Mitchell Dann

Mitchell Dann serves as the Principal and General Partner of Sapient Capital Management LLC. Mr. Dann is also employed at Sapient Capital, L.P., which he founded. He Co-founded Valentx, Inc. in 2002. He has spent over 20 years working with healthcare start-ups, serving as a venture capitalist, advisor, entrepreneur and executive. He is a Co-Founder of Urologix. He served as the Acting Chief Executive Officer on two separate occasions at Urologix. At Urologix, Mr. Dann also served as a Board Member for 14 years and as Chairman of the Board from 1993 to 2003. He joined Investment Advisers, Inc. (IAI) in 1982 as a buy side Analyst following emerging growth companies in the Upper Midwest. In 1983, Mr. Dann co-founded IAI Venture Capital Group. While at IAI Venture Capital Group, his investment focus was healthcare and was responsible for investments in 18 companies and several venture capital partnerships. Mr. Dann served as Vice President, Partner and anaging Partner and under his leadership, the funds under management grew to over $150 million from 1983 to 1991. He also was responsible for investments in Digital Microwave Corporation, International Healthcare Corporation; Mycogen, Inc. Quantum Health Resources, Inc., Tricare, Neurocare and several other companies. He serves as the Chairman of ValenTx, Inc. He served as its Chairman since February 25, 2008. Mr. Dann serves as a Director of Hemosphere, Inc. He served as a Lead Director of Urologix Inc., since August 2008. He served as a Director of TranS1, Inc. until June 23, 2011. He served as a Director of Mitralif. He was the Chairman of Oncotherapeutics, Inc. and a Director of Endotherapeutics, Inc., Endosonics, Inc., Teltech, Inc., and Delphax Technologies, Inc. Mr. Dann serves on the Advisory Board of the Medical Technology Leadership Forum. He received a B.Sc. Degree in Engineering.